Definium Therapeutics, Inc. Financing Cash Flow
Definium Therapeutics, Inc. (DFTX) reported Financing Cash Flow of $767.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $762.27M, a 3779.22% increase year-over-year.
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $5.31M, a 429.84% increase year-over-year.
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $245.87M, a 6358.31% increase year-over-year.
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $749.00K, a 98.92% decline year-over-year.
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $267.27M, a 5.56% increase from fiscal 2024.
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $253.20M, a 1058.90% increase from fiscal 2023.
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $21.85M, a 63.00% decline from fiscal 2022.
- Definium Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $59.05M, a 40.25% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 7 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $762.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $767.58M 10-Q · filed 2026-08-06 | $1.01B derived: sum of 3 quarters · filed 2026-08-06 | $1.01B derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $5.31M 10-Q · filed 2026-05-07 | $251.18M derived: sum of 2 quarters · filed 2026-05-07 | $251.93M derived: sum of 3 quarters · filed 2026-05-07 | $271.58M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $245.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $246.62M derived: sum of 2 quarters · filed 2026-02-26 | $266.27M derived: sum of 3 quarters · filed 2026-08-06 | $267.27M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $749.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $20.40M derived: sum of 2 quarters · filed 2026-08-06 | $21.40M 10-Q · filed 2025-11-06 | $25.21M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $19.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $20.65M 10-Q · filed 2026-08-06 | $24.46M derived: sum of 3 quarters · filed 2026-08-06 | $93.81M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-07 | $4.81M derived: sum of 2 quarters · filed 2026-05-07 | $74.16M derived: sum of 3 quarters · filed 2026-05-07 | $84.95M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $73.16M derived: sum of 2 quarters · filed 2026-02-26 | $83.95M derived: sum of 3 quarters · filed 2026-02-26 | $253.20M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $69.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $80.14M derived: sum of 2 quarters · filed 2025-11-06 | $249.39M 10-Q · filed 2025-11-06 | $251.98M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | $10.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $180.03M 10-Q · filed 2025-07-31 | $182.63M derived: sum of 3 quarters · filed 2025-07-31 | $200.03M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $169.25M 10-Q · filed 2025-05-08 | $171.84M derived: sum of 2 quarters · filed 2025-05-08 | $189.24M derived: sum of 3 quarters · filed 2025-05-08 | $190.51M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $19.99M derived: sum of 2 quarters · filed 2025-03-06 | $21.27M derived: sum of 3 quarters · filed 2025-03-06 | $21.85M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $17.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $18.67M derived: sum of 2 quarters · filed 2024-11-07 | $19.25M 10-Q · filed 2024-11-07 | $19.67M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.86M 10-Q · filed 2024-08-13 | $2.27M derived: sum of 3 quarters · filed 2024-08-13 | $60.48M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $583.00K 10-Q · filed 2024-05-08 | $999.00K derived: sum of 2 quarters · filed 2024-05-08 | $59.21M derived: sum of 3 quarters · filed 2024-05-08 | $59.80M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $58.63M derived: sum of 2 quarters · filed 2024-02-28 | $59.22M derived: sum of 3 quarters · filed 2024-02-28 | $59.05M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $58.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $58.80M derived: sum of 2 quarters · filed 2023-11-02 | $58.63M 10-Q · filed 2023-11-02 | $58.76M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $424.00K 10-Q · filed 2023-08-03 | $551.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.37M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$166.00K 10-Q · filed 2023-05-04 | -$39.00K derived: sum of 2 quarters · filed 2023-05-04 | $781.00K derived: sum of 3 quarters · filed 2023-05-04 | $8.67M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $947.00K derived: sum of 2 quarters · filed 2023-03-09 | $8.84M derived: sum of 3 quarters · filed 2023-03-09 | $98.82M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $820.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $8.71M derived: sum of 2 quarters · filed 2022-11-10 | $98.70M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $7.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $97.88M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $89.99M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $96.70M 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | $9.90M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |